Article info

Download PDFPDF
Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy

Authors

  1. Address correspondence and reprint requests to Snežana M. Bošnjak, MD, PhD, Department of Supportive Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. E-mail: nena.bosnjak@gmail.com.

Citation

Bošnjak SM, Stamatovic L, Borroni ME, et al
Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy

Publication history

  • Received October 30, 2017
  • First published June 1, 2018.
Online issue publication 
June 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.